Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021;50(3):245-261.
doi: 10.1159/000514155. Epub 2021 Mar 23.

Stroke Care during the COVID-19 Pandemic: International Expert Panel Review

Affiliations
Review

Stroke Care during the COVID-19 Pandemic: International Expert Panel Review

Narayanaswamy Venketasubramanian et al. Cerebrovasc Dis. 2021.

Abstract

Background: Coronavirus disease 2019 (COVID-19) has placed a tremendous strain on healthcare services. This study, prepared by a large international panel of stroke experts, assesses the rapidly growing research and personal experience with COVID-19 stroke and offers recommendations for stroke management in this challenging new setting: modifications needed for prehospital emergency rescue and hyperacute care; inpatient intensive or stroke units; posthospitalization rehabilitation; follow-up including at-risk family and community; and multispecialty departmental developments in the allied professions.

Summary: The severe acute respiratory syndrome coronavirus 2 uses spike proteins binding to tissue angiotensin-converting enzyme (ACE)-2 receptors, most often through the respiratory system by virus inhalation and thence to other susceptible organ systems, leading to COVID-19. Clinicians facing the many etiologies for stroke have been sobered by the unusual incidence of combined etiologies and presentations, prominent among them are vasculitis, cardiomyopathy, hypercoagulable state, and endothelial dysfunction. International standards of acute stroke management remain in force, but COVID-19 adds the burdens of personal protections for the patient, rescue, and hospital staff and for some even into the postdischarge phase. For pending COVID-19 determination and also for those shown to be COVID-19 affected, strict infection control is needed at all times to reduce spread of infection and to protect healthcare staff, using the wealth of well-described methods. For COVID-19 patients with stroke, thrombolysis and thrombectomy should be continued, and the usual early management of hypertension applies, save that recent work suggests continuing ACE inhibitors and ARBs. Prothrombotic states, some acute and severe, encourage prophylactic LMWH unless bleeding risk is high. COVID-19-related cardiomyopathy adds risk of cardioembolic stroke, where heparin or warfarin may be preferable, with experience accumulating with DOACs. As ever, arteritis can prove a difficult diagnosis, especially if not obvious on the acute angiogram done for clot extraction. This field is under rapid development and may generate management recommendations which are as yet unsettled, even undiscovered. Beyond the acute management phase, COVID-19-related stroke also forces rehabilitation services to use protective precautions. As with all stroke patients, health workers should be aware of symptoms of depression, anxiety, insomnia, and/or distress developing in their patients and caregivers. Postdischarge outpatient care currently includes continued secondary prevention measures. Although hoping a COVID-19 stroke patient can be considered cured of the virus, those concerned for contact safety can take comfort in the increasing use of telemedicine, which is itself a growing source of patient-physician contacts. Many online resources are available to patients and physicians. Like prior challenges, stroke care teams will also overcome this one. Key Messages: Evidence-based stroke management should continue to be provided throughout the patient care journey, while strict infection control measures are enforced.

Keywords: Coronavirus disease 2019; Management; Review; Stroke.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to declare.

Figures

Fig. 1
Fig. 1
Pathway identifying suspected COVID-19 patients for thrombectomy to treat stroke caused by LVO: note that assessment begins in the prehospital setting and continues into the Emergency Department, culminating with consultation provided by Stroke Neurology. LVO, large vessel occlusion; PPE, personal protective equipment; PAPR, powered air-purifying respirator; PCS, protected code stroke (see Khosravani et al. [30 ]); *droplet/contact PPE (fully sleeved gown, face mask, eye protection, and gloves); **airborne/droplet/contact PPE (droplet/contact PPE with use of N95 mask and face shield or PAPR device).
Fig. 2
Fig. 2
Social distancing is the new order in the OPD waiting areas with a restricted number of patient attendants. OPD, outpatient department.
Fig. 3
Fig. 3
Adopting distancing in the physician practice environment.

References

    1. World Health Organization Coronavirus disease (COVID-19) weekly epidemiological update. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situatio... Accessed 2020 Nov 25.
    1. Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2019;50((12)):e344–418. - PubMed
    1. Wuhan-Hu-1 (Wuhan seafood market pneumonia virus isolate) complete genome. Bethesda, MD: Nucleotide, National Library of Medicine (United States), National Center for Biotechnology Information; Available from: https://www.ncbi.nlm.nih.gov/nuccore/1798174254.
    1. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395((10223)):497–506. - PMC - PubMed
    1. Li X, Geng M, Peng Y, Meng L, Lu S. Molecular immune pathogenesis and diagnosis of COVID-19. J Pharm Anal. 2020;10((2)):102–8. - PMC - PubMed

MeSH terms

Substances